These treatments target hormones that regulate appetite, metabolism, and insulin
Unlike FDA-approved injectable tirzepatide (sold under brand names like Mounjaro and Zepbound ), oral drop versions have not been proven safe or effective in large human clinical trials
For example, in a study of almost 17,000 people published in JAMA Ophthalmology in 2024, researchers found an increased risk of NAION among individuals prescribed semaglutide relative to those prescribed other medications to treat type-2 diabetes and obesity
This bypasses your digestive system entirely
Fewer hospital visits: By decreasing the risk of medical emergencies related to obesity-related comorbid conditions, we help members avoid unnecessary hospital admissions and high-cost specialty visits
PubMed laboratory research record [PMID: 27186127] PubMed record related to this compound for laboratory literature review